SEC FORM 4
$241,412.36
CORCEPT THERAPEUTICS INC (CORT)
Sale of 2,086 shares at $115.7298 per share.
Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code S
Traded Oct 2, 2026 · Disclosed Oct 5, 2026
Source: SEC Form 4 · 0001193125-26-414688 · filed 2026-10-05 · View filing →